Frontiers in Cell and Developmental Biology

metrics 2024

Pioneering research for a deeper understanding of life.

Introduction

Frontiers in Cell and Developmental Biology is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of fundamental biological processes at the cellular and developmental levels. Since its inception in 2013, the journal has positioned itself as a cornerstone of research in its field, achieving esteemed Q1 quartile rankings in both Cell Biology and Developmental Biology for 2023. With a robust Scopus ranking of #13 out of 82 in Developmental Biology and #67 out of 285 in Cell Biology, it represents a vital platform for innovative research and scholarly discourse. The journal provides a comprehensive and accessible avenue for researchers, professionals, and students alike to share high-quality findings and insights into cellular mechanisms and developmental processes, fostering collaboration and knowledge exchange in the global scientific community. Based in Lausanne, Switzerland, Frontiers in Cell and Developmental Biology is committed to open science, ensuring that all articles are freely accessible to the public, thereby broadening the impact of research in the biological sciences.

Metrics 2024

SCIMAGO Journal Rank1.58
Journal Impact Factor4.60
Journal Impact Factor (5 years)5.20
H-Index103
Journal IF Without Self4.60
Eigen Factor0.09
Normal Eigen Factor20.08
Influence1.32
Immediacy Index0.80
Cited Half Life2.70
Citing Half Life7.80
JCI0.85
Total Documents10506
WOS Total Citations46541
SCIMAGO Total Citations96147
SCIMAGO SELF Citations2982
Scopus Journal Rank1.58
Cites / Document (2 Years)4.55
Cites / Document (3 Years)5.00
Cites / Document (4 Years)5.10

Metrics History

Rank 2024

Scopus

Developmental Biology in Biochemistry, Genetics and Molecular Biology
Rank #13/82
Percentile 84.15
Quartile Q1
Cell Biology in Biochemistry, Genetics and Molecular Biology
Rank #67/285
Percentile 76.49
Quartile Q1

IF (Web Of Science)

CELL BIOLOGY
Rank 70/205
Percentile 66.10
Quartile Q2
DEVELOPMENTAL BIOLOGY
Rank 5/39
Percentile 88.50
Quartile Q1

JCI (Web Of Science)

CELL BIOLOGY
Rank 77/205
Percentile 62.44
Quartile Q2
DEVELOPMENTAL BIOLOGY
Rank 10/39
Percentile 74.36
Quartile Q2

Quartile History

Similar Journals

MOLECULAR BIOLOGY OF THE CELL

Driving Breakthroughs in Molecular Research
Publisher: AMER SOC CELL BIOLOGYISSN: 1059-1524Frequency: 13 issues/year

MOLECULAR BIOLOGY OF THE CELL is a prestigious journal published by the American Society for Cell Biology, focusing on the latest advancements in cell biology and molecular biology. Established in 1990, this journal serves as a vital forum for disseminating innovative research, methodologies, and insights that drive the understanding of cellular processes and their implications in health and disease. With a noteworthy impact factor and recognition within the top quartiles for both Cell Biology and Molecular Biology, it ranks prominently among its peers, with Scopus rankings reflecting its significance in the scientific community. Although the journal does not follow an open access model, it provides essential access options for both institutional and personal subscriptions. Researchers, professionals, and students seeking to expand their knowledge and collaborate on groundbreaking findings will find MOLECULAR BIOLOGY OF THE CELL an invaluable resource in the field.

DNA AND CELL BIOLOGY

Exploring the Frontiers of Molecular Discovery
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

Organogenesis

Advancing the Frontiers of Developmental Biology.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

DEVELOPMENT

Connecting groundbreaking research with future biological innovations.
Publisher: COMPANY BIOLOGISTS LTDISSN: 0950-1991Frequency: 24 issues/year

DEVELOPMENT is a preeminent journal published by COMPANY BIOLOGISTS LTD, headquartered in the United Kingdom. With an ISSN of 0950-1991 and an E-ISSN of 1477-9129, this esteemed journal has been at the forefront of the fields of Developmental Biology and Molecular Biology since its inception in 1987. Recognized for its rigorous peer review process and high-caliber research, DEVELOPMENT holds an impressive Q1 ranking in both disciplines as of 2023, underscoring its pivotal role in advancing scientific understanding. The journal is particularly noted for its contributions to the understanding of developmental processes, their molecular underpinnings, and their implications in health and disease. With a significant impact factor, DEVELOPMENT aims to disseminate groundbreaking research that inspires novel insights and future explorations within the biological sciences, making it an essential resource for researchers, professionals, and students alike. The journal also maintains accessibility for its readership, ensuring that significant research findings reach those who can apply and build upon them.

EMBO REPORTS

Unveiling Insights in Biochemistry, Genetics, and Beyond
Publisher: WILEYISSN: 1469-221XFrequency: 12 issues/year

EMBO REPORTS, published by WILEY, is a premier journal in the fields of Biochemistry, Genetics, and Molecular Biology, recognized for its rigorous peer-review process and impactful scientific contributions. Established in the year 2000 in the United Kingdom, this journal has maintained a stellar reputation, reflected in its consistent positioning within the Q1 category across these disciplines as of 2023. EMBO REPORTS excels in disseminating high-quality and timely research that addresses fundamental questions and challenges in molecular biology and genetics, making it an invaluable resource for researchers, professionals, and students. With impressive Scopus rankings, including Genetics at the 32nd rank and a 90th percentile placement, it fosters an environment for scholarly exchange and advances in knowledge. While Open Access options are not available, the journal continues to enhance its impact through traditional subscription models, thereby maintaining wide visibility in the scientific community. Its ongoing evolution promises continued relevance and influence until at least 2024.

DIFFERENTIATION

Shaping the Future of Developmental Research
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

CURRENT OPINION IN CELL BIOLOGY

Advancing Insights in Cellular Mechanisms
Publisher: CURRENT BIOLOGY LTDISSN: 0955-0674Frequency: 6 issues/year

CURRENT OPINION IN CELL BIOLOGY, published by CURRENT BIOLOGY LTD, serves as a vital resource for scholars and professionals in the dynamic field of cell biology. With a solid Q1 ranking and impressive Scopus ranking of #33 out of 285 in the category of Cell Biology, this journal is recognized for its high impact and relevance among its peers, boasting an excellent percentile ranking of 88th. Established in 1989, it provides insightful reviews and perspectives that capture the latest developments and emergent trends in cellular research, making it indispensable for those aiming to deepen their understanding of cellular mechanisms and innovations. While the journal does not offer open access, its carefully curated content ensures that subscribers receive top-tier scholarly discourse. Situated in the heart of the United Kingdom, CURRENT OPINION IN CELL BIOLOGY continues to shape the conversation in a field that is critical to advancements in biochemistry, genetics, and molecular biology.

CYTOTECHNOLOGY

Cultivating Discovery: Inspiring New Horizons in Bioengineering and Biotechnology.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

CELL CYCLE

Leading Insights into Molecular and Developmental Biology.
Publisher: TAYLOR & FRANCIS INCISSN: 1538-4101Frequency: 24 issues/year

CELL CYCLE, an esteemed journal published by Taylor & Francis Inc., stands at the forefront of biological research, focusing on the intricate mechanisms of cell proliferation, molecular biology, and developmental biology. With an ISSN of 1538-4101 and an E-ISSN of 1551-4005, this journal has established its influence in the field with a commendable impact factor reflecting its rigorous peer-review process and high-quality publications. Notably, in 2023, it achieved a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in both Cell Biology and Developmental Biology, marking its vital role in advancing scientific understanding and innovation. Operating within a converged framework from 2002 to 2024, CELL CYCLE caters to a diverse audience of researchers, professionals, and students eager to explore contemporary findings and emerging trends. The journal's objective is to disseminate groundbreaking research that enhances our understanding of cellular mechanisms, fostering collaboration and innovation. Although not an open-access journal, it remains a premier source for those engaged in cell cycle research, and its contributions have significant implications for fields such as healthcare, biotechnology, and genetics.

Cells & Development

Connecting Disciplines to Propel Developmental Discoveries
Publisher: ELSEVIERISSN: 2667-2901Frequency: 4 issues/year

Cells & Development is a premier journal published by Elsevier, dedicated to advancing the field of Developmental Biology. With an ISSN of 2667-2901 and an impressive Q2 ranking in its category for 2023, the journal endeavors to provide a platform for high-quality research articles that explore cellular mechanisms, developmental processes, and molecular interactions that underpin growth and differentiation. Based in the Netherlands, Cells & Development not only emphasizes the importance of innovative experimental approaches but also encourages interdisciplinary contributions that bridge the gap between basic and applied science. As an Open Access publication, it ensures that research findings are readily accessible to a global audience, significantly enhancing visibility and impact. The journal's commitment to scholarly excellence makes it an essential resource for researchers, professionals, and students aiming to contribute to the dynamic field of developmental biology.